Penn Medicine Abramson Cancer Center

 

2022 Updates in Care of the Hematologic Malignancies Patient
17:09

Penn Medicine Abramson Cancer Center

Therapeutic Advances in Hodgkin Lymphoma

FEATURING Jakub Svoboda
  • 115 views
  • May 6, 2022
20:59

Penn Medicine Abramson Cancer Center

Penn Medicine Myeloma Panel Discussion & Case Presentation: 75 y/o Female With Smoldering Myeloma

FEATURING Alfred Garfall, Adam Waxman, Stephen Wallace, Sandra Susanibar-Adaniya, Adam D. Cohen, Dan Vogl, Patricia Mangan, Edward Stadtmauer
  • 12 views
  • May 4, 2022
07:30

Penn Medicine Abramson Cancer Center

Penn Medicine HemOnc Panel Discussion: When to Treat Patients With T-Cells, CAR-T as a New SoC for Relapsed Myeloma, CLL Developments, MRD Negativity & Transplant

FEATURING David Porter, Noelle Frey, Stephen Schuster
  • 26 views
  • May 4, 2022
16:11

Penn Medicine Abramson Cancer Center

CAR T-Cells and Immunotherapy for R/R ALL

FEATURING Noelle Frey
  • 14 views
  • May 4, 2022
20:34

Penn Medicine Abramson Cancer Center

Autologous SCT or CAR T-Cells as 2L for R/R Lymphoma

FEATURING David Porter
  • 13 views
  • May 4, 2022
20:48

Penn Medicine Abramson Cancer Center

Penn Medicine HemOnc Panel Discussion: MDS Updates, Induction Therapy for Acute Leukemias, Gene Analysis in Myeloid Disease, Tumor Predisposition Syndrome

FEATURING Shannon McCurdy, Elizabeth Hexner, Ximena Jordan-Bruno, Lindsay Lee, Sunil Saroha
  • 22 views
  • May 4, 2022
14:49

Penn Medicine Abramson Cancer Center

The Direction of Leukemia Treatment Nationally and Around the World: Ongoing and Upcoming Randomized Cooperative Group Trials

FEATURING Selina Luger
  • 319 views
  • May 4, 2022
  • 1
13:08

Penn Medicine Abramson Cancer Center

Penn Medicine Updates in CML and MPNs

FEATURING Elizabeth Hexner
  • 19 views
  • May 4, 2022
22:43

Penn Medicine Abramson Cancer Center

Highlights in the Prognostication of MDS This Year

FEATURING Shannon McCurdy
  • 34 views
  • May 4, 2022
20:14

Penn Medicine Abramson Cancer Center

Emerging Treatment Options for AML

FEATURING Alexander Perl
  • 27 views
  • May 4, 2022
09:18

Penn Medicine Abramson Cancer Center

Penn Medicine Lymphoma Panel Discussion: Toxicity Profile with IO, Salvage Regimen for cHL, Maintenance Rituximab, BTKi for MCL, and 3L Therapy for FL

FEATURING Stephen Schuster, James Gerson, Stefan Barta, Sunita D. Nasta, Elise Chong
  • 21 views
  • May 4, 2022
18:09

Penn Medicine Abramson Cancer Center

Early Disease State: Amyloidosis

FEATURING Adam Waxman
  • 13 views
  • May 2, 2022
19:48

Penn Medicine Abramson Cancer Center

New Therapies for Relapsed Myeloma

FEATURING Dan Vogl
  • 364 views
  • May 2, 2022
23:00

Penn Medicine Abramson Cancer Center

Role of Immunotherapy for Myeloma

FEATURING Adam D. Cohen
  • 206 views
  • May 2, 2022
  • 1
20:58

Penn Medicine Abramson Cancer Center

Initial Therapy for MM Including Transplant

FEATURING Alfred Garfall
  • 50 views
  • May 2, 2022
29:00

Penn Medicine Abramson Cancer Center

Smoldering Myeloma and Myeloma Precursor States

FEATURING Sandra Susanibar-Adaniya
  • 9 views
  • May 2, 2022
16:09

Penn Medicine Abramson Cancer Center

Increasing Access to Allogeneic Hematopoietic Cell Transplantation

FEATURING Alison Loren
  • 1 view
  • May 2, 2022
23:06

Penn Medicine Abramson Cancer Center

DLCL: Immune Modulation Therapy Including CAR-T, Bispecific Antibodies, and New Antibodies

FEATURING Sunita D. Nasta
  • 10 views
  • May 2, 2022
14:12

Penn Medicine Abramson Cancer Center

Targeted Therapy for Aggressive B-Cell Lymphoma

FEATURING Daniel Landsburg
  • 8 views
  • May 2, 2022
19:45

Penn Medicine Abramson Cancer Center

Therapeutic Advances in T-Cell Lymphoma

FEATURING Stefan Barta
  • 33 views
  • May 2, 2022
13:41

Penn Medicine Abramson Cancer Center

New Therapies for Mantle Cell Lymphoma

FEATURING James Gerson
  • 13 views
  • May 2, 2022
29:12

Penn Medicine Abramson Cancer Center

Equitable Access to Hematologic Malignancies Research for Everyone

FEATURING Carmen Guerra
  • 61 views
  • May 2, 2022